CoChat
Sign Up
Cited by 19

The DOI matches its Crossref record.

ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line

Celestino, Andréa Turbuck, Levy, Débora, Maria Ruiz, Jorge Luis, Bydlowski, Sérgio Paulo·2015·Biochemical and Biophysical Research Communications
DOI 10.1016/j.bbrc.2015.01.045
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2015.01.045

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Gayet, 2005, Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells, Biochemistry, 44, 4499, 10.1021/bi048669w · DOI
  2. Ambudkar, 2003, P-glycoprotein: from genomics to mechanism, Oncogene, 22, 7468, 10.1038/sj.onc.1206948 · DOI
  3. Ruiz, 2013, Interrelationship between ATP-binding cassette transporters and oxysterols, Biochem. Pharmacol., 86, 80, 10.1016/j.bcp.2013.02.033 · DOI
  4. Rothnie, 2001, The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence, Eur. Biophys. J., 30, 430, 10.1007/s002490100156 · DOI
  5. Bacso, 2004, Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein, Cytom. A, 61, 105, 10.1002/cyto.a.20081 · DOI
  6. Orlowski, 2006, P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?), Cell. Mol. Life Sci., 63, 1038, 10.1007/s00018-005-5554-9 · DOI
  7. Troost, 2004, Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells, Biochem. Biophys. Res. Commun., 316, 705, 10.1016/j.bbrc.2004.02.102 · DOI · Paper page
  8. Cole, 1992, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science, 258, 1650, 10.1126/science.1360704 · DOI · Paper page
  9. Bakos, 2007, Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1), Pflugers Arch., 453, 621, 10.1007/s00424-006-0160-8 · DOI
  10. Munoz, 2007, Role of the MRP1/ABCC1 multidrug transporter protein in cancer, IUBMB Life, 59, 752, 10.1080/15216540701736285 · DOI
  11. Mossink, 2003, Vaults: a ribonucleoprotein particle involved in drug resistance?, Oncogene, 22, 7458, 10.1038/sj.onc.1206947 · DOI
  12. Eckford, 2008, Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport, Biochemistry, 47, 13686, 10.1021/bi801409r · DOI
  13. Garrigues, 2002, The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane, Proc. Natl. Acad. Sci. U S A, 99, 10347, 10.1073/pnas.162366399 · DOI
  14. Levy, 2014, Short-term effects of 7-ketocholesterol on human adipose tissue mesenchymal stem cells in vitro, Biochem. Biophys. Res. Commun., 446, 720, 10.1016/j.bbrc.2014.01.132 · DOI
  15. Bydlowski, 1987, Ontogeny of 6-keto-PGF1 alpha synthesis in rabbit aorta and the effect of premature weaning, Am. J. Physiol., 252, H14
  16. Hungria, 2004, Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease, Cancer Chemother. Pharmacol., 53, 51, 10.1007/s00280-003-0692-y · DOI
  17. Shu, 2007, Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line, Biochem. Cell. Biol., 85, 638, 10.1139/o07-065 · DOI
  18. Connelly-Smith, 2007, P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors, Exp. Hematol., 35, 1793, 10.1016/j.exphem.2007.07.017 · DOI
  19. Sprinkle, 1987, Studies on aorta during development. II. Differences in ontogeny of the key enzymes involved in cholesteryl ester synthesis and hydrolysis in rabbit aorta, Atherosclerosis, 67, 71, 10.1016/0021-9150(87)90266-8 · DOI
  20. Metherall, 1996, Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis, J. Biol. Chem., 271, 2634, 10.1074/jbc.271.5.2634 · DOI
  21. Debry, 1997, Role of multidrug resistance P-glycoproteins in cholesterol esterification, J. Biol. Chem., 272, 1026, 10.1074/jbc.272.2.1026 · DOI
  22. Field, 1998, Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum, J. Lipid Res., 39, 333, 10.1016/S0022-2275(20)33895-5 · DOI
  23. Le Goff, 2006, Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis, J. Lipid Res., 47, 51, 10.1194/jlr.M500255-JLR200 · DOI
  24. Sinicrope, 1992, Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles, J. Biol. Chem., 267, 24995, 10.1016/S0021-9258(19)73996-9 · DOI
  25. Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182 · DOI
  26. Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI
  27. Harker, 1985, Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA, Cancer Res., 45, 4091
  28. Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  29. Kamau, 2005, Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells, In Vitro Cell. Dev. Biol. Anim., 41, 207, 10.1290/0502016.1 · DOI
  30. Sharom, 2014, Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function, Front. Oncol., 4, 41, 10.3389/fonc.2014.00041 · DOI
  31. Lavie, 1998, Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells, J. Biol. Chem., 273, 32380, 10.1074/jbc.273.49.32380 · DOI
  32. Liscovitch, 2000, Multidrug resistance: a role for cholesterol efflux pathways?, Trends Biochem. Sci., 25, 530, 10.1016/S0968-0004(00)01668-6 · DOI
  33. Bosch, 1997, Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein, Biochemistry, 36, 5685, 10.1021/bi962728r · DOI
  34. Pohl, 2002, Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line, Biochem. J., 365, 259, 10.1042/bj20011880 · DOI
  35. Wang, 2000, Cholesterol interaction with the daunorubicin binding site of P-glycoprotein, Biochem. Biophys. Res. Commun., 276, 909, 10.1006/bbrc.2000.3554 · DOI
  36. Troost, 2004, Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells, Mol. Pharmacol., 66, 1332, 10.1124/mol.104.002329 · DOI
  37. Luker, 2000, Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains, Biochemistry, 39, 8692, 10.1021/bi005112h · DOI
  38. Fenyvesi, 2008, P-glycoprotein inhibition by membrane cholesterol modulation, Eur. J. Pharm. Sci., 34, 236, 10.1016/j.ejps.2008.04.005 · DOI

Cited by

Sorted by citations

Metadata

Authors
Celestino, A. T., Levy, D., Maria Ruiz, J. L., & Bydlowski, S. P.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2015-02
Volume
457
Issue
4
Pages
664-668
ISSN
0006-291X
DOI
10.1016/j.bbrc.2015.01.045
Cited by
19
References
0
Language
en
Licence
Funders
  • Instituto Nacional de Ciência e Tecnologia de Fluidos Complexos
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Instituto Nacional de Ciência e Tecnologia de Estudos do Espaço

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review